Emerging roles of RNA-binding proteins in diabetes and their therapeutic potential in diabetic complications

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Diabetes affects over 422 million globally, causing severe multisystemic complications.
• Next-generation RNA sequencing and computational methods reveal aberrant posttranscriptional gene regulation in diabetes.
• RNA-binding proteins (RBPs) are key regulators of RNA networks, and their dysregulation is implicated in diabetes pathogenesis.

Purpose of the Study:

• To discuss the emerging roles of RNA-binding proteins (RBPs) in abnormal posttranscriptional gene expression in diabetes.
• To identify disrupted posttranscriptional mechanisms and the specific RBPs involved in diabetic conditions.
• To explore how RBP dysregulation contributes to diabetes and assess the potential of RNA-based therapeutic strategies targeting RBPs.

Main Methods:

• Review of recent advancements in high-throughput RNA sequencing and computational algorithms.
• Analysis of human genetic studies linking RBP polymorphisms and mutations to diabetes.
• Discussion of RBP alterations and their functional consequences in diabetic pathogenesis.

Main Results:

• Aberrant posttranscriptional gene regulatory programs are discovered in diabetes through advanced sequencing and computational analyses.
• Human genetic studies provide evidence linking polymorphisms and mutations in RBPs to diabetes.
• RBPs are identified as crucial regulators whose dysregulation contributes to abnormal gene expression in diabetic conditions.

Conclusions:

• Studying the evolving roles of RBPs in diabetes is critical for understanding disease pathogenesis.
• Targeting RBPs using RNA-based methods may offer novel therapeutic approaches for diabetic complications.
• Further research into RBP function is essential for developing effective treatments for diabetes.